Back
Hartford US Quality Growth ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
82
HQGO
Hartford US Quality Growth ETF
Last Price:
$52.29
Seasonality Move:
4.57%
Sell
30
SRPT
Sarepta Therapeutics
Last Price:
$17.10
Seasonality Move:
17.08%
Buy
82
Hartford US Quality Growth ETF (HQGO)
is a Buy
Is Hartford US Quality Growth ETF a Buy, Sell or Hold?
-
The current Hartford US Quality Growth ETF [HQGO] share price is $54.05. The Score for HQGO is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
HQGO is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
30
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $17.11. The Score for SRPT is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HQGO Stock Price Chart
What is Hartford US Quality Growth ETF's stock price today?
-
The Hartford US Quality Growth ETF share price today is $54.05The current trend is moderately bearish and HQGO is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $17.11Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
HQGO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 64.94 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.13 - 53.39) | Buy |
| Bollinger Bands (100): | (48.23 - 53.63) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.1 | Sell |
| Relative Strength Index (14 RSI): | 18.51 | Sell |
| Chaikin Money Flow: | -2892309 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.2 - 41) | Sell |
| Bollinger Bands (100): | (34.03 - 95.19) | Sell |
HQGO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.14 | Buy |
| 20-day SMA: | 52.97 | Buy |
| 50-day SMA: | 51.21 | Buy |
| 200-day SMA: | 51.59 | Buy |
| 8-day EMA: | 53.37 | Buy |
| 20-day EMA: | 52.88 | Buy |
| 50-day EMA: | 51.86 | Buy |
| 200-day EMA: | 50.7 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.01 | Sell |
| 20-day SMA: | 29.95 | Sell |
| 50-day SMA: | 40.46 | Sell |
| 200-day SMA: | 93.66 | Sell |
| 8-day EMA: | 20.36 | Sell |
| 20-day EMA: | 27.35 | Sell |
| 50-day EMA: | 40.52 | Sell |
| 200-day EMA: | 81.56 | Sell |
Hartford US Quality Growth ETF Earnings Growth & HQGO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.86 per share, a decrease this year of $5.90 per share, and an increase next year of $5.54 per share.
Hartford US Quality Growth ETF Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||